切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2026, Vol. 12 ›› Issue (03) : 272 -278. doi: 10.3877/cma.j.issn.2096-1537.2026.03.007

年度进展

重症患者肠道功能障碍的机制、评估与干预的研究进展
贾如, 尚伟锋, 陈德昌†()   
  1. 200025 上海,上海交通大学医学院附属瑞金医院重症医学科
  • 收稿日期:2026-01-28 出版日期:2026-08-28
  • 通信作者: 陈德昌
  • 基金资助:
    国家自然科学基金项目(82241044,82172152)

Advances in mechanisms, assessment, and intervention for intestinal dysfunction in critically ill patients

Ru Jia, Weifeng Shang, Dechang Chen†()   

  1. Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  • Received:2026-01-28 Published:2026-08-28
  • Corresponding author: Dechang Chen
引用本文:

贾如, 尚伟锋, 陈德昌. 重症患者肠道功能障碍的机制、评估与干预的研究进展[J/OL]. 中华重症医学电子杂志, 2026, 12(03): 272-278.

Ru Jia, Weifeng Shang, Dechang Chen. Advances in mechanisms, assessment, and intervention for intestinal dysfunction in critically ill patients[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2026, 12(03): 272-278.

重症患者的肠道功能障碍与多器官功能障碍综合征的发生发展及预后密切相关。本文系统回顾了2025年间该领域的整合进展。首先,重点阐述危重症状态下肠道屏障损伤与菌群失调的病理生理机制,及其与急性胃肠损伤的关联,并提及腹腔高压/腹腔间隔室综合征等严重后果。其次,系统总结目前临床常用的肠道功能评估体系,包括基于生物标志物与影像学的客观评估工具,以及胃肠功能障碍评分等整合性评分系统。进一步阐述了肠道通过“肠-器官轴”介导全身炎症反应与远隔器官损伤的分子机制。在干预策略方面,重点评述了微生态调控(如益生菌、粪菌移植、短链脂肪酸补充)与优化肠内营养、抗生素合理应用等综合管理措施的最新证据。未来仍需开展更多高质量临床研究,推动肠道功能障碍的评估与干预向个体化、精准化方向发展,以改善重症患者临床结局。

Intestinal dysfunction in critically ill patients is closely related to the development and prognosis of multiple organ dysfunction syndrome. This article systematically reviews the integrative progress in this field in 2025. First, it focuses on elucidating the pathophysiological mechanisms of intestinal barrier damage and microbiome dysbiosis in critically ill patients and their association with acute gastrointestinal injury, and mentions serious consequences such as intra-abdominal hypertension/abdominal compartment syndrome. Second, it systematically summarizes currently used clinical intestinal function assessment systems, including objective assessment tools based on biomarkers and imaging, and integrative scoring systems such as the gastrointestinal dysfunction score. Furthermore, it summarizes the mechanisms by which the gut mediates systemic inflammatory responses and distant organ damage through the gut-organ axis. Regarding interventions, it reviews microecological regulation strategies represented by probiotics, fecal microbiota transplantation, and short-chain fatty acid supplementation, as well as comprehensive management measures such as optimized enteral nutrition practices and rational use of antibiotics. Future research must prioritize high-quality clinical trials to drive the assessment and intervention of intestinal dysfunction toward individualization and precision, ultimately improving clinical outcomes for critically ill patients.

图1 重症患者肠道功能障碍的机制与应对 注:IAH为腹腔高压;ACS为腹腔间隔室综合征;AGI为急性胃肠损伤;GIDS为胃肠功能障碍评分;FMT为粪菌移植;SCFAs为短链脂肪酸
1
Deitch EA. Gut-origin sepsis: evolution of a concept[J]. Surgeon, 2012, 10(6): 350-356.
2
Klingensmith NJ, Coopersmith CM. The gut as the motor of multiple organ dysfunction in critical illness[J]. Crit Care Clin, 2016, 32(2): 203-212.
3
Neurath MF, Artis D, Becker C. The intestinal barrier: a pivotal role in health, inflammation, and cancer[J]. Lancet Gastroenterol Hepatol, 2025, 10(6): 573-592.
4
Pellegrini C, Fornai M, D'Antongiovanni V, et al. The intestinal barrier in disorders of the central nervous system[J]. Lancet Gastroenterol Hepatol, 2023, 8(1): 66-80.
5
Wang X, Peng J, Cai P, et al. The emerging role of the gut microbiota and its application in inflammatory bowel disease[J]. Biomed Pharmacother, 2024, 179: 117302.
6
Cho NA, Strayer K, Dobson B, et al. Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness[J]. Gut Microbes, 2024, 16(1): 2351478.
7
Battaglini D, Torres A. Gut microbiota and its impact on critical illness[J]. Curr Opin Crit Care, 2025, 31(2): 189-197.
8
White Z, Cabrera I, Mei L, et al. Gut inflammation promotes microbiota-specific CD4 T cell-mediated neuroinflammation[J]. Nature, 2025, 643(8071): 509-518.
9
Patel JJ, Barash M. The gut in critical illness[J]. Curr Gastroenterol Rep, 2025, 27(1): 11.
10
中国抗癌协会肿瘤与微生态专业委员会, 湖北省免疫学会肿瘤与微生态专业委员会. 肠道微生态组学实验室标准化技术规范中国专家共识(2022版)[J]. 中华实验外科杂志, 2024, 41(8): 1873-1882.
11
Zhang D, Li Y, Ding L, et al. Prevalence and outcome of acute gastrointestinal injury in critically ill patients: a systematic review and meta-analysis[J]. Medicine (Baltimore), 2018, 97(43): e12970.
12
Drakos P, Volteas P, Cleri NA, et al. Acute gastrointestinal injury and feeding intolerance as prognostic factors in critically ill COVID-19 patients[J]. J Gastrointest Surg, 2022, 26(1): 181-190.
13
Reintam Blaser A, Malbrain ML, Starkopf J, et al. Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems[J]. Intensive Care Med, 2012, 38(3): 384-394.
14
Hu B, Sun R, Wu A, et al. Severity of acute gastrointestinal injury grade is a predictor of all-cause mortality in critically ill patients: a multicenter, prospective, observational study[J]. Crit Care, 2017, 21(1): 188.
15
亚洲急危重症协会中国腹腔重症协作组. 重症病人胃肠功能障碍肠内营养专家共识 (2021版)[J]. 中华消化外科杂志, 2021, 20(11): 1123-1136.
16
Reintam Blaser A, Padar M, Mändul M, et al. Development of the Gastrointestinal Dysfunction Score (GIDS) for critically ill patients - A prospective multicenter observational study (iSOFA study)[J]. Clin Nutr, 2021, 40(8): 4932-4940.
17
McClave SA, Gualdoni J, Nagengast A, et al. Gastrointestinal dysfunction and feeding intolerance in critical illness: do we need an objective scoring system?[J]. Curr Gastroenterol Rep, 2020, 22(1): 1.
18
Lin J, Liu Y, Ke L, et al. Feeding intolerance score in critically ill patients with enteral nutrition: a post hoc analysis of a prospective study[J]. Nutr Clin Pract, 2022, 37(4): 869-877.
19
de Jong PR, González-Navajas JM, Jansen NJ. The digestive tract as the origin of systemic inflammation[J]. Crit Care, 2016, 20(1): 279.
20
Wang Y, Li Y, Zhang Y, et al. Development and validation of a nomogram for predicting 28-day mortality in critically ill patients with acute gastrointestinal injury: prospective observational study[J]. Front Nutr, 2024, 11: 1469870.
21
Shen C, Wang X, Xiao YY, et al. Comparing gastrointestinal dysfunction score and acute gastrointestinal injury grade for predicting short-term mortality in critically ill patients[J]. World J Gastroenterol, 2024, 30(42): 4523-4531.
22
Xu J, Shi W, Xie L, et al. Feeding intolerance in critically ill patients with enteral nutrition: a Meta-analysis and systematic review[J]. J Crit Care Med (Targu Mures), 2024, 10(1): 7-15.
23
Reintam Blaser A, Regli A, De Keulenaer B, et al. Incidence, risk factors, and outcomes of intra-abdominal hypertension in critically ill patients-a prospective multicenter study (IROI study)[J]. Crit Care Med, 2019, 47(4): 535-542.
24
Sikiric P, Seiwerth S, Skrtic A, et al. Acute compartment syndrome and intra-abdominal hypertension, decompression, current pharmacotherapy, and stable gastric pentadecapeptide BPC 157 solution[J]. Pharmaceuticals (Basel), 2025, 18(6): 866.
25
Sugrue M, Buhkari Y. Intra-abdominal pressure and abdominal compartment syndrome in acute general surgery[J]. World J Surg, 2009, 33(6): 1123-1127.
26
Soranno DE, Coopersmith CM, Brinkworth JF, et al. A review of gut failure as a cause and consequence of critical illness[J]. Crit Care, 2025, 29(1): 91.
27
Wu Y, Zhang Y, Yu Y, et al. Small intestinal γδ T17 cells promote SAE through STING/C1q-induced microglial synaptic pruning in male mice[J]. Nat Commun, 2025, 16(1): 6779.
28
Wu J, Ji K, Kang G, et al. Butyrate-engineered yeast activates Nppa and Sgcg genes and reduces radiation-induced heart damage via the gut-heart axis[J]. Pharmacol Res, 2025, 213: 107642.
29
Zhao J, Zhang Q, Cheng W, et al. Heart-gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia/reperfusion[J]. Cardiovasc Res, 2023, 119(6): 1390-1402.
30
Iwata Y, Nakade Y, Tokumaru T, et al. Gut-Kidney axis: novel insights in kidney diseases[J]. Chem Biodivers, 2025, 22(12): e01506.
31
Xie B, Wang M, Zhang X, et al. Gut-derived memory γδ T17 cells exacerbate sepsis-induced acute lung injury in mice[J]. Nat Commun, 2024, 15(1): 6737.
32
Kaur H, Kaur G, Ali SA. IL-33's role in the gut immune system: a comprehensive review of its crosstalk and regulation[J]. Life Sci, 2023, 327: 121868.
33
Hu JJ, Deng F, Sun QS, et al. Time-restricted feeding protects against septic liver injury by reshaping gut microbiota and metabolite 3-hydroxybutyrate[J]. Gut Microbes, 2025, 17(1): 2486515.
34
Wang Y, Zhang Y, Liu Y, et al. Gut-liver axis: liver sinusoidal endothelial cells function as the hepatic barrier in colitis-induced liver injury[J]. Front Cell Dev Biol, 2021, 9: 702890.
35
Kang EJ, Cha MG, Kwon GH, et al. Akkermansia muciniphila improve cognitive dysfunction by regulating BDNF and serotonin pathway in gut-liver-brain axis[J]. Microbiome, 2024, 12(1): 181.
36
Cheng Y, Hu G, Deng L, et al. Therapeutic role of gut microbiota in lung injury-related cognitive impairment[J]. Front Nutr, 2024, 11: 1521214.
37
Guarino M, Di Ciaula A, Portincasa P, et al. Narrative review on microbiota and sepsis: the host's betrayal?[J]. Intern Emerg Med, 2026, 21(2): 607-619.
38
Lee ZY, Lew C, Ortiz-Reyes A, et al. Benefits and harm of probiotics and synbiotics in adult critically ill patients. A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis[J]. Clin Nutr, 2023, 42(4): 519-531.
39
Dehghani MH, Saghafi F, Bordbari Z, et al. Investigating the effect of oral synbiotic on enteral feeding tolerance in critically ill patients: a double-blinded controlled clinical trial of gut microbiota[J]. Nutr Clin Pract, 2023, 38(2): 402-410.
40
Oliwa-Libumska K, Jaworska-Czerwinska A, Mallek-Grabowska M, et al. Fecal microbiota transplantation in a patient hospitalized in the intensive care unit - case report[J]. Heliyon, 2025, 11(4): e42793.
41
Xu Z, Wang T, Wang Y, et al. Short-chain fatty acids: key antiviral mediators of gut microbiota[J]. Front Immunol, 2025, 16: 1614879.
42
Hegelmaier T, Duscha A, Desel C, et al. Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective study[J]. Sci Rep, 2025, 16(1): 315.
43
黄曼, 丁朔. 脓毒症的诊治现状及挑战[J]. 诊断学理论与实践, 2025, 24(6): 583-592.
44
Martin ND, Schott LL, Miranowski MK, et al. Exploring the impact of arginine-supplemented immunonutrition on length of stay in the intensive care unit: a retrospective cross-sectional analysis[J]. PLoS One, 2024, 19(4): e0302074.
45
Koch JL, Lew C, Kork F, et al. The efficacy of fiber-supplemented enteral nutrition in critically ill patients: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis[J]. Crit Care, 2024, 28(1): 359.
46
Ramaswamy T, DeWane MP, Dashti HS, et al. Nine myths about enteral feeding in critically ill adults: an expert perspective[J]. Adv Nutr, 2025, 16(1): 100345.
47
Michailidou EM. Management of gastrointestinal failure in the adult critical care environment[J/OL]. Journal of Gastroenterology & Hepatology Reports, 2025, 6(5): 1-6.
48
Kokai-Kun JF, Roberts T, Coughlin O, et al. Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial[J]. Lancet Infect Dis, 2019, 19(5): 487-496.
49
Messaoudene M, Ferreira S, Saint-Lu N, et al. The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase Ⅰ trial in healthy volunteers[J]. Nat Commun, 2024, 15(1): 8083.
50
Cusumano G, Flores GA, Venanzoni R, et al. The impact of antibiotic therapy on intestinal microbiota: dysbiosis, antibiotic resistance, and restoration strategies[J]. Antibiotics (Basel), 2025, 14(4): 371.
[1] 高宇, 郑薇, 李丽丽, 钟威, 魏乾伟, 李一辰. 基于CiteSpace的我国儿童肠道菌群领域研究热点及趋势的文献计量学分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2026, 22(03): 239-249.
[2] 冉金玲, 冯卓慧, 赵智. 孕妇低剂量抗菌药物应用对新生儿肠道菌群影响的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2026, 22(02): 103-108.
[3] 施健华, 张剑, 宋海兵, 顾颖浩. 胆囊切除术后综合征的临床诊疗进展[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(06): 606-609.
[4] 肖攀云, 吴晓玲, 郝晓敏, 卫飞飞, 杨薇. 贝达喹啉合并肠内营养支持治疗对57例耐多药肺结核的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 106-111.
[5] 薛伟伟, 杜凯豪, 汪占金, 东小鸽, 何洁洁, 罗兰明慧, 蒋威, 王展. 遗传学视角孟德尔随机化分析东亚人群肠道菌群与原发性肝癌因果关系[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 79-88.
[6] 张瑞豪, 李文星. 肠道微生物组在结直肠癌化疗中的双向调控作用[J/OL]. 中华结直肠疾病电子杂志, 2026, 15(03): 269-273.
[7] 王珍. 基于"肠-肾"轴探讨"内热致癥"病机在糖尿病肾病中的应用[J/OL]. 中华肾病研究电子杂志, 2026, 15(01): 60-60.
[8] 张玉坤, 田磊, 接英, 保佳玉, 白芸, 王娟, 邵琦妍, 刘晶, 吴彬阁. 中重度干眼患者肠道菌群特征及其与眼表稳态相关性的临床研究[J/OL]. 中华眼科医学杂志(电子版), 2026, 16(03): 153-159.
[9] 冯毅, 贾耿, 陈璐, 秦华平, 杨常春, 邵耐远, 彭亚. 可溶性膳食纤维对重症脑出血患者肠道微生态的影响[J/OL]. 中华神经创伤外科电子杂志, 2026, 12(01): 30-38.
[10] 温珍亮, 刘绍泽, 刘娇. 重症胃肠:2025[J/OL]. 中华重症医学电子杂志, 2026, 12(02): 124-128.
[11] 刘佳鑫, 张泽, 张黎. 肠道菌群与糖尿病神经病变间的因果推断:通过循环代谢物和蛋白质介导的两步孟德尔随机化研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2026, 16(03): 135-149.
[12] 曹丽静, 郭锦荣, 包喜文. 穴位贴敷联合益肠通秘汤治疗慢传输型便秘的疗效及对胃肠激素和肠道菌群的影响[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(05): 474-480.
[13] 张天民, 颜尧, 张先云, 吴自余, 王苏贵, 姜福金. 草酸钙尿路结石患者肠道菌群结构与靶向代谢谱的关联特征研究[J/OL]. 中华临床医师杂志(电子版), 2026, 20(05): 351-360.
[14] 潘赛波, 韩佳, 吴明, 于振涛. 食管癌患者围手术期肠内营养置管及通路管理专家共识[J/OL]. 中华胸部外科电子杂志, 2026, 13(01): 1-13.
[15] 刘超然, 刘志慧. 袖状胃切除术后体重恢复的生物学机制与阶梯式管理策略[J/OL]. 中华肥胖与代谢病电子杂志, 2026, 12(02): 120-124.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?